546 related articles for article (PubMed ID: 18167537)
21. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.
Reynolds AD; Banerjee R; Liu J; Gendelman HE; Mosley RL
J Leukoc Biol; 2007 Nov; 82(5):1083-94. PubMed ID: 17675560
[TBL] [Abstract][Full Text] [Related]
22. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
[TBL] [Abstract][Full Text] [Related]
23. Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse.
Song LK; Ma KL; Yuan YH; Mu Z; Song XY; Niu F; Han N; Chen NH
PLoS One; 2015; 10(6):e0131281. PubMed ID: 26114655
[TBL] [Abstract][Full Text] [Related]
24. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
25. Association between SGK1 and α-synuclein in skeletal muscle in an MPTP-induced Parkinson's disease model.
Heo EJ; Lee Y; Hyung Seo M; Yeo S
Neurosci Lett; 2023 Sep; 814():137464. PubMed ID: 37634811
[TBL] [Abstract][Full Text] [Related]
26. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.
Gao HM; Kotzbauer PT; Uryu K; Leight S; Trojanowski JQ; Lee VM
J Neurosci; 2008 Jul; 28(30):7687-98. PubMed ID: 18650345
[TBL] [Abstract][Full Text] [Related]
27. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
Schutt CR; Gendelman HE; Mosley RL
Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
[TBL] [Abstract][Full Text] [Related]
28. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
29. α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys.
Vermilyea SC; Guthrie S; Hernandez I; Bondarenko V; Emborg ME
Cell Transplant; 2019 Apr; 28(4):379-387. PubMed ID: 30857404
[TBL] [Abstract][Full Text] [Related]
30. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.
Reynolds AD; Stone DK; Mosley RL; Gendelman HE
J Immunol; 2009 Apr; 182(7):4137-49. PubMed ID: 19299711
[TBL] [Abstract][Full Text] [Related]
31. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
32. Acupuncture Inhibits the Increase in Alpha-Synuclein by Modulating SGK1 in an MPTP Induced Parkinsonism Mouse Model.
Yeo S; Lim S
Am J Chin Med; 2019; 47(3):527-539. PubMed ID: 30966771
[TBL] [Abstract][Full Text] [Related]
33. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.
Theodore S; Cao S; McLean PJ; Standaert DG
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1149-58. PubMed ID: 19018246
[TBL] [Abstract][Full Text] [Related]
34. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
35. The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease.
Mariucci G; Pagiotti R; Galli F; Romani L; Conte C
J Mol Neurosci; 2018 Apr; 64(4):611-618. PubMed ID: 29589201
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
37. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
38. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
[TBL] [Abstract][Full Text] [Related]
39. Acupuncture Inhibits the Increase in Alpha-Synuclein in Substantia Nigra in an MPTP- Induced Parkinsonism Mouse Model.
Yeo S; Song J; Lim S
Adv Exp Med Biol; 2020; 1232():401-408. PubMed ID: 31893437
[TBL] [Abstract][Full Text] [Related]
40. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
Stoll AC; Sortwell CE
Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
